Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 157 | 2024 | 5821 | 12.160 |
Why?
|
Melanoma | 111 | 2024 | 5709 | 8.490 |
Why?
|
Sunbathing | 21 | 2020 | 65 | 6.960 |
Why?
|
Ultraviolet Rays | 27 | 2024 | 1080 | 4.000 |
Why?
|
Early Detection of Cancer | 37 | 2024 | 3201 | 3.390 |
Why?
|
Sunburn | 22 | 2018 | 156 | 3.200 |
Why?
|
Beauty Culture | 13 | 2018 | 41 | 3.140 |
Why?
|
Health Education | 25 | 2019 | 1052 | 3.020 |
Why?
|
Sunscreening Agents | 24 | 2024 | 139 | 2.600 |
Why?
|
Counseling | 20 | 2022 | 1547 | 2.500 |
Why?
|
Dermatology | 19 | 2022 | 918 | 2.390 |
Why?
|
Smoking Cessation | 20 | 2022 | 2056 | 2.390 |
Why?
|
Dermoscopy | 15 | 2022 | 66 | 2.340 |
Why?
|
Neoplasms, Radiation-Induced | 10 | 2024 | 549 | 2.070 |
Why?
|
Carcinoma, Basal Cell | 10 | 2024 | 560 | 2.020 |
Why?
|
Mass Screening | 29 | 2024 | 5428 | 2.000 |
Why?
|
Public Housing | 5 | 2022 | 140 | 1.970 |
Why?
|
Nevus | 11 | 2022 | 205 | 1.960 |
Why?
|
Self-Examination | 16 | 2020 | 71 | 1.950 |
Why?
|
Sunlight | 16 | 2024 | 337 | 1.910 |
Why?
|
Physical Examination | 13 | 2020 | 1255 | 1.650 |
Why?
|
Health Knowledge, Attitudes, Practice | 28 | 2024 | 4016 | 1.640 |
Why?
|
Parents | 13 | 2024 | 3563 | 1.620 |
Why?
|
Health Behavior | 23 | 2018 | 2643 | 1.480 |
Why?
|
Health Promotion | 14 | 2022 | 2214 | 1.470 |
Why?
|
Tobacco Smoke Pollution | 7 | 2022 | 819 | 1.410 |
Why?
|
Students, Medical | 17 | 2021 | 1936 | 1.380 |
Why?
|
Patient Education as Topic | 16 | 2020 | 2319 | 1.320 |
Why?
|
Education, Medical, Undergraduate | 12 | 2016 | 1070 | 1.320 |
Why?
|
Clinical Competence | 22 | 2022 | 4792 | 1.310 |
Why?
|
Schools, Medical | 14 | 2021 | 879 | 1.160 |
Why?
|
Directive Counseling | 5 | 2016 | 170 | 1.140 |
Why?
|
Tobacco Use Disorder | 9 | 2016 | 703 | 1.090 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2024 | 4026 | 1.060 |
Why?
|
Education, Medical | 9 | 2021 | 1725 | 0.990 |
Why?
|
Education, Distance | 2 | 2019 | 261 | 0.990 |
Why?
|
United States | 94 | 2024 | 72334 | 0.990 |
Why?
|
Minors | 2 | 2015 | 58 | 0.950 |
Why?
|
Public Health | 8 | 2023 | 2669 | 0.940 |
Why?
|
Cultural Competency | 3 | 2019 | 300 | 0.940 |
Why?
|
School Health Services | 9 | 2008 | 384 | 0.930 |
Why?
|
Primary Prevention | 9 | 2018 | 1186 | 0.910 |
Why?
|
Cosmetics | 4 | 2012 | 102 | 0.900 |
Why?
|
Primary Health Care | 9 | 2024 | 4686 | 0.890 |
Why?
|
Pediatric Nursing | 3 | 2014 | 104 | 0.860 |
Why?
|
Humans | 245 | 2024 | 761504 | 0.860 |
Why?
|
Curriculum | 20 | 2024 | 3743 | 0.850 |
Why?
|
Pamphlets | 2 | 2020 | 71 | 0.850 |
Why?
|
Child, Hospitalized | 3 | 2014 | 182 | 0.830 |
Why?
|
Cosmetic Techniques | 2 | 2015 | 149 | 0.790 |
Why?
|
Adolescent Behavior | 5 | 2020 | 1190 | 0.770 |
Why?
|
Male | 149 | 2024 | 360804 | 0.760 |
Why?
|
Early Diagnosis | 9 | 2020 | 1186 | 0.730 |
Why?
|
Preceptorship | 2 | 2018 | 56 | 0.720 |
Why?
|
Female | 152 | 2024 | 392644 | 0.720 |
Why?
|
Physicians, Primary Care | 7 | 2020 | 623 | 0.710 |
Why?
|
Nevus, Pigmented | 6 | 2022 | 222 | 0.710 |
Why?
|
Suntan | 4 | 2015 | 17 | 0.680 |
Why?
|
Neoplasms, Basal Cell | 1 | 2019 | 31 | 0.660 |
Why?
|
Cross-Sectional Studies | 35 | 2024 | 26125 | 0.660 |
Why?
|
Incidence | 30 | 2024 | 21353 | 0.660 |
Why?
|
Adult | 98 | 2024 | 221177 | 0.660 |
Why?
|
Young Adult | 47 | 2024 | 59243 | 0.660 |
Why?
|
SEER Program | 13 | 2021 | 1450 | 0.640 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2019 | 95 | 0.640 |
Why?
|
Clinical Clerkship | 7 | 2016 | 564 | 0.640 |
Why?
|
Adolescent | 64 | 2024 | 88319 | 0.640 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2018 | 61 | 0.630 |
Why?
|
Quarantine | 1 | 2020 | 181 | 0.610 |
Why?
|
Photography | 6 | 2015 | 532 | 0.610 |
Why?
|
Foundations | 1 | 2018 | 95 | 0.600 |
Why?
|
Social Support | 2 | 2020 | 2171 | 0.600 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2019 | 592 | 0.590 |
Why?
|
Parent-Child Relations | 4 | 2020 | 761 | 0.580 |
Why?
|
Social Isolation | 1 | 2020 | 364 | 0.580 |
Why?
|
Tobacco Industry | 1 | 2018 | 136 | 0.570 |
Why?
|
General Practitioners | 1 | 2018 | 101 | 0.570 |
Why?
|
Law Enforcement | 2 | 2015 | 112 | 0.540 |
Why?
|
Middle Aged | 78 | 2024 | 220895 | 0.530 |
Why?
|
Community Health Services | 2 | 2018 | 656 | 0.530 |
Why?
|
Neoplasms | 9 | 2021 | 22170 | 0.520 |
Why?
|
Research Support as Topic | 2 | 2018 | 697 | 0.520 |
Why?
|
Hotlines | 1 | 2016 | 55 | 0.520 |
Why?
|
Financing, Organized | 1 | 2017 | 204 | 0.510 |
Why?
|
Government Regulation | 3 | 2016 | 524 | 0.500 |
Why?
|
Facility Regulation and Control | 1 | 2015 | 24 | 0.490 |
Why?
|
Risk Factors | 42 | 2024 | 74206 | 0.490 |
Why?
|
Sexual Partners | 1 | 2020 | 796 | 0.490 |
Why?
|
Europe | 7 | 2022 | 3422 | 0.480 |
Why?
|
Smoking | 11 | 2016 | 9053 | 0.480 |
Why?
|
Skin Care | 2 | 2006 | 57 | 0.480 |
Why?
|
Health Personnel | 5 | 2024 | 3335 | 0.460 |
Why?
|
Students | 5 | 2018 | 1741 | 0.460 |
Why?
|
Biomedical Research | 4 | 2018 | 3429 | 0.450 |
Why?
|
Education, Medical, Continuing | 6 | 2021 | 823 | 0.450 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2017 | 793 | 0.450 |
Why?
|
Pediatrics | 7 | 2024 | 3589 | 0.450 |
Why?
|
Health Services Needs and Demand | 3 | 2021 | 1403 | 0.450 |
Why?
|
Health Policy | 9 | 2020 | 2684 | 0.440 |
Why?
|
Child | 45 | 2024 | 80153 | 0.440 |
Why?
|
Information Dissemination | 2 | 2019 | 1126 | 0.440 |
Why?
|
Parental Consent | 1 | 2013 | 63 | 0.430 |
Why?
|
United States Food and Drug Administration | 4 | 2020 | 1664 | 0.430 |
Why?
|
Massachusetts | 19 | 2022 | 8830 | 0.430 |
Why?
|
Online Systems | 2 | 2019 | 182 | 0.420 |
Why?
|
Internal Medicine | 2 | 2018 | 1051 | 0.410 |
Why?
|
Self Efficacy | 8 | 2024 | 638 | 0.410 |
Why?
|
Physician's Role | 2 | 2013 | 917 | 0.410 |
Why?
|
Survivors | 4 | 2023 | 2371 | 0.410 |
Why?
|
Barbering | 1 | 2011 | 9 | 0.400 |
Why?
|
Body Mass Index | 5 | 2024 | 12953 | 0.390 |
Why?
|
Life Style | 4 | 2024 | 3917 | 0.390 |
Why?
|
Data Collection | 8 | 2013 | 3322 | 0.390 |
Why?
|
Sex Factors | 14 | 2024 | 10552 | 0.380 |
Why?
|
Stomatognathic Diseases | 1 | 2010 | 22 | 0.370 |
Why?
|
Forecasting | 7 | 2018 | 2928 | 0.360 |
Why?
|
Alaska | 3 | 2019 | 69 | 0.360 |
Why?
|
Expert Testimony | 1 | 2013 | 364 | 0.360 |
Why?
|
Epidemics | 2 | 2013 | 512 | 0.360 |
Why?
|
Aged | 47 | 2024 | 169289 | 0.350 |
Why?
|
Consumer Advocacy | 1 | 2010 | 82 | 0.350 |
Why?
|
Health Priorities | 1 | 2013 | 374 | 0.350 |
Why?
|
Guideline Adherence | 1 | 2020 | 2220 | 0.350 |
Why?
|
House Calls | 1 | 2011 | 161 | 0.350 |
Why?
|
Sexual Behavior | 1 | 2020 | 2180 | 0.340 |
Why?
|
Body Weight | 2 | 2018 | 4618 | 0.330 |
Why?
|
Insurance, Health | 2 | 2019 | 2498 | 0.320 |
Why?
|
Skin | 5 | 2020 | 4484 | 0.320 |
Why?
|
Health Plan Implementation | 2 | 2016 | 337 | 0.320 |
Why?
|
Community-Based Participatory Research | 3 | 2019 | 221 | 0.310 |
Why?
|
Program Evaluation | 9 | 2018 | 2495 | 0.310 |
Why?
|
Health Care Surveys | 7 | 2021 | 2426 | 0.310 |
Why?
|
Public Health Administration | 1 | 2010 | 242 | 0.300 |
Why?
|
Health Status Disparities | 3 | 2020 | 1852 | 0.300 |
Why?
|
Health Services Accessibility | 5 | 2021 | 5440 | 0.300 |
Why?
|
Focus Groups | 6 | 2019 | 1413 | 0.300 |
Why?
|
Age Factors | 14 | 2020 | 18395 | 0.300 |
Why?
|
Parenting | 2 | 2015 | 701 | 0.300 |
Why?
|
Program Development | 5 | 2018 | 1297 | 0.290 |
Why?
|
Telephone | 3 | 2024 | 627 | 0.290 |
Why?
|
Socioeconomic Factors | 6 | 2021 | 7827 | 0.280 |
Why?
|
Research | 2 | 2013 | 1982 | 0.270 |
Why?
|
Attitude | 1 | 2012 | 775 | 0.270 |
Why?
|
Germany | 6 | 2018 | 875 | 0.270 |
Why?
|
Registries | 7 | 2018 | 8224 | 0.270 |
Why?
|
Sex Distribution | 9 | 2016 | 2281 | 0.270 |
Why?
|
California | 5 | 2020 | 1429 | 0.270 |
Why?
|
Internet | 4 | 2017 | 3092 | 0.270 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2024 | 5671 | 0.270 |
Why?
|
Communication | 5 | 2022 | 3873 | 0.260 |
Why?
|
Age Distribution | 10 | 2016 | 2880 | 0.260 |
Why?
|
Military Personnel | 1 | 2015 | 1246 | 0.260 |
Why?
|
Risk Assessment | 15 | 2023 | 23995 | 0.260 |
Why?
|
Gynecology | 1 | 2011 | 526 | 0.250 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.250 |
Why?
|
Protective Clothing | 6 | 2008 | 103 | 0.250 |
Why?
|
Neoplasms, Second Primary | 3 | 2021 | 1052 | 0.250 |
Why?
|
Overweight | 4 | 2024 | 2417 | 0.250 |
Why?
|
Pilot Projects | 10 | 2021 | 8631 | 0.250 |
Why?
|
Communications Media | 1 | 2005 | 42 | 0.240 |
Why?
|
Poverty | 4 | 2018 | 2698 | 0.240 |
Why?
|
Internship and Residency | 4 | 2022 | 5880 | 0.240 |
Why?
|
Databases, Factual | 2 | 2019 | 7967 | 0.240 |
Why?
|
Burns | 1 | 2016 | 1882 | 0.240 |
Why?
|
Obstetrics | 1 | 2011 | 665 | 0.240 |
Why?
|
Competency-Based Education | 2 | 2005 | 222 | 0.230 |
Why?
|
Multivariate Analysis | 12 | 2019 | 12059 | 0.230 |
Why?
|
Medically Uninsured | 2 | 2020 | 836 | 0.230 |
Why?
|
Nuclear Family | 2 | 2016 | 311 | 0.230 |
Why?
|
Air Pollution, Indoor | 1 | 2011 | 901 | 0.230 |
Why?
|
Health Surveys | 6 | 2020 | 4061 | 0.230 |
Why?
|
Biopsy, Needle | 4 | 2015 | 1626 | 0.230 |
Why?
|
Residence Characteristics | 1 | 2014 | 2093 | 0.230 |
Why?
|
Siblings | 3 | 2007 | 825 | 0.230 |
Why?
|
Self Report | 2 | 2013 | 3724 | 0.230 |
Why?
|
Aged, 80 and over | 18 | 2021 | 58976 | 0.220 |
Why?
|
Social Class | 2 | 2012 | 2004 | 0.220 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5336 | 0.220 |
Why?
|
School Nursing | 3 | 2009 | 33 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.210 |
Why?
|
Risk-Taking | 4 | 2017 | 1038 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 440 | 0.200 |
Why?
|
Physicians, Family | 1 | 2004 | 350 | 0.200 |
Why?
|
Spectrum Analysis | 2 | 2014 | 453 | 0.200 |
Why?
|
Bibliometrics | 1 | 2006 | 352 | 0.200 |
Why?
|
Texas | 2 | 2015 | 404 | 0.200 |
Why?
|
Family | 2 | 2012 | 3194 | 0.200 |
Why?
|
Queensland | 3 | 2015 | 52 | 0.200 |
Why?
|
Michigan | 1 | 2022 | 339 | 0.200 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3358 | 0.190 |
Why?
|
Geography | 2 | 2021 | 656 | 0.190 |
Why?
|
Societies, Medical | 5 | 2020 | 3905 | 0.190 |
Why?
|
Occupational Exposure | 1 | 2011 | 1813 | 0.190 |
Why?
|
Computer-Assisted Instruction | 2 | 2016 | 362 | 0.190 |
Why?
|
Australasia | 1 | 2020 | 21 | 0.190 |
Why?
|
Epidemiologic Factors | 1 | 2020 | 36 | 0.190 |
Why?
|
Mass Media | 2 | 2014 | 303 | 0.190 |
Why?
|
North America | 2 | 2024 | 1276 | 0.180 |
Why?
|
Prevalence | 10 | 2020 | 15732 | 0.180 |
Why?
|
Nurse's Role | 3 | 2011 | 188 | 0.180 |
Why?
|
Illinois | 2 | 2015 | 120 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.180 |
Why?
|
Motivation | 3 | 2022 | 2006 | 0.180 |
Why?
|
Time Factors | 11 | 2019 | 39967 | 0.180 |
Why?
|
Microscopy, Confocal | 3 | 2016 | 1971 | 0.180 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 495 | 0.180 |
Why?
|
Attitude to Health | 6 | 2016 | 2025 | 0.170 |
Why?
|
Research Personnel | 2 | 2017 | 588 | 0.170 |
Why?
|
Oregon | 2 | 2021 | 148 | 0.170 |
Why?
|
Risk Reduction Behavior | 3 | 2011 | 1112 | 0.170 |
Why?
|
Professional Competence | 2 | 2012 | 431 | 0.160 |
Why?
|
Child, Preschool | 15 | 2019 | 42230 | 0.160 |
Why?
|
Educational Status | 4 | 2012 | 2522 | 0.160 |
Why?
|
Adult Children | 1 | 2019 | 103 | 0.160 |
Why?
|
Drug Labeling | 2 | 2014 | 248 | 0.160 |
Why?
|
Television | 2 | 2016 | 408 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2009 | 2639 | 0.150 |
Why?
|
Organ Transplantation | 1 | 2008 | 1157 | 0.150 |
Why?
|
Rural Population | 2 | 2019 | 2285 | 0.150 |
Why?
|
Referral and Consultation | 2 | 2024 | 3600 | 0.150 |
Why?
|
Air Pollutants | 1 | 2011 | 2896 | 0.150 |
Why?
|
Boston | 6 | 2018 | 9326 | 0.140 |
Why?
|
Logistic Models | 5 | 2019 | 13255 | 0.140 |
Why?
|
Educational Measurement | 4 | 2013 | 1254 | 0.140 |
Why?
|
Intention | 2 | 2017 | 347 | 0.140 |
Why?
|
Life Expectancy | 1 | 2024 | 1242 | 0.140 |
Why?
|
Feedback | 2 | 2018 | 791 | 0.140 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7390 | 0.140 |
Why?
|
Advisory Committees | 3 | 2016 | 787 | 0.130 |
Why?
|
Patient Compliance | 2 | 2006 | 2690 | 0.130 |
Why?
|
Hospital Administration | 1 | 2020 | 353 | 0.130 |
Why?
|
Brazil | 1 | 2020 | 1230 | 0.130 |
Why?
|
Regression Analysis | 5 | 2015 | 6343 | 0.130 |
Why?
|
Follow-Up Studies | 11 | 2021 | 39106 | 0.130 |
Why?
|
Medical Oncology | 1 | 2008 | 2321 | 0.130 |
Why?
|
Friends | 1 | 2017 | 149 | 0.130 |
Why?
|
Qualitative Research | 4 | 2021 | 3023 | 0.130 |
Why?
|
Nevada | 1 | 2015 | 22 | 0.130 |
Why?
|
Schools | 2 | 2020 | 1489 | 0.130 |
Why?
|
Indians, North American | 1 | 2019 | 352 | 0.130 |
Why?
|
Interviews as Topic | 3 | 2018 | 2696 | 0.130 |
Why?
|
Vermont | 1 | 2015 | 81 | 0.130 |
Why?
|
Minority Groups | 1 | 2023 | 1203 | 0.130 |
Why?
|
Prognosis | 12 | 2020 | 29625 | 0.120 |
Why?
|
Tanning | 1 | 2014 | 10 | 0.120 |
Why?
|
Technology | 1 | 2017 | 292 | 0.120 |
Why?
|
Family Characteristics | 1 | 2020 | 1004 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1001 | 0.120 |
Why?
|
United States Environmental Protection Agency | 3 | 2008 | 139 | 0.120 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11121 | 0.120 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1463 | 0.120 |
Why?
|
Beauty | 1 | 2014 | 41 | 0.120 |
Why?
|
Biomedical Technology | 1 | 2017 | 211 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 595 | 0.120 |
Why?
|
Mothers | 2 | 2016 | 2198 | 0.120 |
Why?
|
Telepathology | 1 | 2015 | 77 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1668 | 0.120 |
Why?
|
China | 1 | 2020 | 2369 | 0.120 |
Why?
|
South Africa | 1 | 2020 | 1842 | 0.120 |
Why?
|
Income | 1 | 2023 | 1877 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10209 | 0.110 |
Why?
|
Afghan Campaign 2001- | 1 | 2015 | 298 | 0.110 |
Why?
|
Politics | 1 | 2020 | 815 | 0.110 |
Why?
|
Survival Analysis | 5 | 2015 | 10090 | 0.110 |
Why?
|
Nursing Methodology Research | 1 | 2013 | 64 | 0.110 |
Why?
|
Probability | 3 | 2004 | 2477 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2018 | 554 | 0.110 |
Why?
|
Models, Nursing | 1 | 2013 | 46 | 0.110 |
Why?
|
Learning | 2 | 2022 | 1740 | 0.110 |
Why?
|
Healthy People Programs | 1 | 2013 | 54 | 0.110 |
Why?
|
Mentors | 1 | 2018 | 661 | 0.110 |
Why?
|
Peer Group | 2 | 2017 | 692 | 0.110 |
Why?
|
Connecticut | 1 | 2013 | 364 | 0.110 |
Why?
|
Skin Pigmentation | 2 | 2024 | 277 | 0.110 |
Why?
|
Eye Protective Devices | 1 | 2012 | 33 | 0.110 |
Why?
|
Organizational Policy | 3 | 2011 | 432 | 0.110 |
Why?
|
Massage | 1 | 2013 | 86 | 0.100 |
Why?
|
Drug Approval | 1 | 2020 | 814 | 0.100 |
Why?
|
Community-Institutional Relations | 3 | 2020 | 206 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2018 | 803 | 0.100 |
Why?
|
Confidence Intervals | 5 | 2019 | 2927 | 0.100 |
Why?
|
Bathing Beaches | 1 | 2012 | 12 | 0.100 |
Why?
|
Population Surveillance | 2 | 2020 | 2598 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5840 | 0.100 |
Why?
|
State Government | 1 | 2015 | 384 | 0.100 |
Why?
|
Safety Management | 1 | 2018 | 760 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3416 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 931 | 0.100 |
Why?
|
Faculty, Medical | 2 | 2012 | 1203 | 0.100 |
Why?
|
Infant | 6 | 2019 | 36192 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2022 | 80636 | 0.090 |
Why?
|
Cohort Studies | 10 | 2024 | 41487 | 0.090 |
Why?
|
Industry | 1 | 2013 | 364 | 0.090 |
Why?
|
Hypertension | 1 | 2010 | 8540 | 0.090 |
Why?
|
Research Design | 3 | 2017 | 6180 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2023 | 3060 | 0.090 |
Why?
|
Administrative Personnel | 1 | 2011 | 184 | 0.090 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11460 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.090 |
Why?
|
Legislation as Topic | 1 | 2010 | 77 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.080 |
Why?
|
Academies and Institutes | 1 | 2012 | 318 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 709 | 0.080 |
Why?
|
Canada | 1 | 2015 | 2122 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1436 | 0.080 |
Why?
|
Occupations | 1 | 2011 | 515 | 0.080 |
Why?
|
Social Medicine | 1 | 2010 | 64 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1359 | 0.080 |
Why?
|
Physician-Patient Relations | 2 | 2013 | 3249 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9757 | 0.080 |
Why?
|
Models, Educational | 2 | 2014 | 373 | 0.080 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2011 | 395 | 0.080 |
Why?
|
Teaching Materials | 1 | 2008 | 84 | 0.080 |
Why?
|
Mortality | 2 | 2013 | 2901 | 0.070 |
Why?
|
Cause of Death | 3 | 2024 | 3683 | 0.070 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.070 |
Why?
|
Holidays | 1 | 2007 | 40 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6935 | 0.070 |
Why?
|
Culture | 2 | 2009 | 623 | 0.070 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 3688 | 0.070 |
Why?
|
Behavior, Addictive | 1 | 2012 | 462 | 0.070 |
Why?
|
Mother-Child Relations | 1 | 2011 | 495 | 0.070 |
Why?
|
Obesity | 1 | 2009 | 12947 | 0.070 |
Why?
|
Biopsy | 2 | 2016 | 6766 | 0.070 |
Why?
|
Prospective Studies | 9 | 2020 | 54425 | 0.070 |
Why?
|
Spouses | 1 | 2009 | 283 | 0.070 |
Why?
|
Florida | 2 | 2005 | 431 | 0.070 |
Why?
|
Medicaid | 1 | 2019 | 2818 | 0.070 |
Why?
|
Aging | 2 | 2020 | 8708 | 0.060 |
Why?
|
Color | 1 | 2006 | 299 | 0.060 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2005 | 88 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4481 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3205 | 0.060 |
Why?
|
Personnel Selection | 1 | 2007 | 196 | 0.060 |
Why?
|
Workplace | 1 | 2011 | 863 | 0.060 |
Why?
|
Child Day Care Centers | 1 | 2005 | 122 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11118 | 0.060 |
Why?
|
Heliotherapy | 1 | 2003 | 2 | 0.060 |
Why?
|
Teaching | 3 | 2007 | 1170 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1250 | 0.060 |
Why?
|
Triage | 1 | 2011 | 986 | 0.060 |
Why?
|
Awareness | 2 | 2005 | 648 | 0.060 |
Why?
|
Weather | 1 | 2005 | 231 | 0.060 |
Why?
|
Self Care | 1 | 2009 | 796 | 0.060 |
Why?
|
Caregivers | 1 | 2016 | 2237 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2016 | 3188 | 0.050 |
Why?
|
Needs Assessment | 1 | 2009 | 1139 | 0.050 |
Why?
|
Cocarcinogenesis | 1 | 2003 | 49 | 0.050 |
Why?
|
Immunocompromised Host | 1 | 2008 | 856 | 0.050 |
Why?
|
Role Playing | 1 | 2003 | 22 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3051 | 0.050 |
Why?
|
Odds Ratio | 5 | 2019 | 9646 | 0.050 |
Why?
|
International Cooperation | 1 | 2009 | 1422 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15266 | 0.050 |
Why?
|
Aftercare | 1 | 2008 | 914 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2021 | 4174 | 0.050 |
Why?
|
Radiation Protection | 1 | 2006 | 424 | 0.050 |
Why?
|
Remission, Spontaneous | 2 | 2014 | 384 | 0.050 |
Why?
|
Professional Role | 1 | 2024 | 314 | 0.050 |
Why?
|
Swimming | 1 | 2002 | 208 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2019 | 26198 | 0.050 |
Why?
|
Seasons | 1 | 2007 | 1520 | 0.050 |
Why?
|
Veterans | 1 | 2015 | 2647 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1386 | 0.050 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2005 | 380 | 0.050 |
Why?
|
Keratinocytes | 1 | 2024 | 790 | 0.040 |
Why?
|
Tax Exemption | 1 | 2020 | 14 | 0.040 |
Why?
|
Models, Statistical | 1 | 2015 | 5079 | 0.040 |
Why?
|
Government Programs | 1 | 2002 | 279 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4542 | 0.040 |
Why?
|
Mitotic Index | 1 | 2019 | 162 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
Drug Industry | 1 | 2006 | 788 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3595 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2008 | 6228 | 0.040 |
Why?
|
Environmental Exposure | 2 | 2005 | 4486 | 0.040 |
Why?
|
Universities | 2 | 2017 | 993 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 2020 | 0.040 |
Why?
|
Hungary | 1 | 2018 | 82 | 0.040 |
Why?
|
New York | 1 | 2021 | 874 | 0.040 |
Why?
|
Netherlands | 1 | 2022 | 2221 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11669 | 0.040 |
Why?
|
Economics, Hospital | 1 | 2020 | 210 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 573 | 0.040 |
Why?
|
Greece | 1 | 2018 | 340 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2008 | 2775 | 0.040 |
Why?
|
Longitudinal Studies | 5 | 2016 | 14605 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11076 | 0.040 |
Why?
|
Morbidity | 1 | 2003 | 1750 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2373 | 0.040 |
Why?
|
Housing | 1 | 2022 | 670 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6484 | 0.030 |
Why?
|
Choice Behavior | 1 | 2003 | 824 | 0.030 |
Why?
|
Medical Records Systems, Computerized | 1 | 2003 | 1192 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 64680 | 0.030 |
Why?
|
Survival Rate | 3 | 2016 | 12725 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15500 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6391 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3267 | 0.030 |
Why?
|
Diet | 2 | 2015 | 8075 | 0.030 |
Why?
|
Philadelphia | 1 | 2016 | 266 | 0.030 |
Why?
|
Cost-Benefit Analysis | 3 | 2018 | 5492 | 0.030 |
Why?
|
Exercise | 2 | 2009 | 5890 | 0.030 |
Why?
|
Preventive Medicine | 1 | 2016 | 246 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 22176 | 0.030 |
Why?
|
Linear Models | 1 | 2004 | 5871 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
Skin Diseases | 1 | 2002 | 1094 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1893 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14666 | 0.030 |
Why?
|
Computer User Training | 1 | 2012 | 19 | 0.030 |
Why?
|
Computer Simulation | 1 | 2007 | 6240 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8002 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20098 | 0.030 |
Why?
|
Death Certificates | 1 | 2012 | 167 | 0.020 |
Why?
|
Hospitalization | 2 | 2022 | 10723 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7237 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4591 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2015 | 741 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 2 | 2008 | 1722 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2014 | 763 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 882 | 0.020 |
Why?
|
Psychometrics | 1 | 2019 | 3065 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2510 | 0.020 |
Why?
|
Informed Consent | 1 | 2016 | 1008 | 0.020 |
Why?
|
Video Recording | 1 | 2015 | 966 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2016 | 980 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12463 | 0.020 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2013 | 328 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2011 | 500 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2021 | 3029 | 0.020 |
Why?
|
Community Networks | 1 | 2010 | 201 | 0.020 |
Why?
|
Energy Intake | 1 | 2015 | 2134 | 0.020 |
Why?
|
Public Health Practice | 1 | 2010 | 219 | 0.020 |
Why?
|
Patient Preference | 1 | 2015 | 924 | 0.020 |
Why?
|
Biometry | 1 | 2010 | 563 | 0.020 |
Why?
|
Hospitals, General | 1 | 2011 | 798 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2825 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3882 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13380 | 0.020 |
Why?
|
Public Opinion | 1 | 2010 | 484 | 0.020 |
Why?
|
Mental Recall | 1 | 2012 | 1214 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2008 | 537 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6814 | 0.020 |
Why?
|
Student Health Services | 1 | 2004 | 40 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.010 |
Why?
|
Self-Assessment | 1 | 2007 | 396 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.010 |
Why?
|
Health Care Costs | 2 | 2008 | 3242 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 966 | 0.010 |
Why?
|
Colorado | 1 | 2003 | 165 | 0.010 |
Why?
|
Hawaii | 1 | 2002 | 102 | 0.010 |
Why?
|
Quality of Life | 3 | 2011 | 13367 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2004 | 363 | 0.010 |
Why?
|
Baltimore | 1 | 2003 | 231 | 0.010 |
Why?
|
Sports | 1 | 2008 | 705 | 0.010 |
Why?
|
Sarcoma | 1 | 2013 | 1801 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17904 | 0.010 |
Why?
|
Environment Design | 1 | 2002 | 173 | 0.010 |
Why?
|
Health Care Reform | 1 | 2010 | 1247 | 0.010 |
Why?
|
Nicotine | 1 | 2005 | 680 | 0.010 |
Why?
|
Drug Utilization | 1 | 2005 | 1188 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16591 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2002 | 992 | 0.010 |
Why?
|
Microscopy | 1 | 2004 | 903 | 0.010 |
Why?
|
Child Welfare | 1 | 2002 | 521 | 0.010 |
Why?
|
Cost of Illness | 1 | 2007 | 1936 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15842 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6346 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2002 | 21012 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 6990 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9280 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10508 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12974 | 0.010 |
Why?
|